EDITORIAL
Published on 21 Sep 2022
Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
doi 10.3389/fmed.2022.1020859
- 903 views
- Frontiers in Medicine
- Rheumatology
- Research Topics
- Advance In B-cell therapies For The Treatment of Rheumatic and Musculoskeletal Diseases
Advance In B-cell therapies For The Treatment of Rheumatic and Musculoskeletal Diseases
21k
Total Downloads
84k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 28 Oct 2021
Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
doi 10.3389/fmed.2021.765535
- 2,413 views
- 4 citations
REVIEW
Published on 05 Feb 2021
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
doi 10.3389/fmed.2020.607725
- 12,944 views
- 45 citations
CASE REPORT
Published on 28 Oct 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
doi 10.3389/fmed.2020.553075
- 3,618 views
- 9 citations
ORIGINAL RESEARCH
Published on 08 Sep 2020
Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren's Syndrome: A Retrospective Analysis in a Real-Life Setting
doi 10.3389/fmed.2020.00534
- 1,955 views
- 6 citations
BRIEF RESEARCH REPORT
Published on 27 Aug 2020
Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
doi 10.3389/fmed.2020.00498
- 3,514 views
- 17 citations
REVIEW
Published on 09 Jul 2020
B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
doi 10.3389/fmed.2020.00316
- 16,830 views
- 63 citations
REVIEW
Published on 30 Jun 2020
Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
doi 10.3389/fmed.2020.00303
- 31,417 views
- 71 citations
BRIEF RESEARCH REPORT
Published on 27 May 2020
Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus
doi 10.3389/fmed.2020.00222
- 4,249 views
- 20 citations
ORIGINAL RESEARCH
Published on 07 Apr 2020
Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission
doi 10.3389/fmed.2020.00085
- 5,203 views
- 34 citations
Published in
Frontiers in Medicine
- Rheumatology
Impact
- 84kTopic views
- 61kArticle views
- 21kArticle downloads